Myofascial pain syndrome: Efficacy of different therapies

Journal of Back and Musculoskeletal Rehabilitation

Volumn 20, Issue 1, 2007, Pages 43-47

  Esenyel, Meltem ^a   Aldemir, Tayfun ^a   Gürsoy, Esra ^a   Esenyel, Cem Zeki ^a   Demir, Saliha ^a   Durmuşoǧlu, Gülis ^a  

^a VAKIF GUREBA HOSPITAL   (Turkey)

Author keywords

Botulinum toxin; Lidocaine; Myofascial pain; Ultrasound treatment

Indexed keywords

BOTULINUM TOXIN A; LIDOCAINE;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE FATIGUE; MUSCLE STRETCHING; MYOFASCIAL PAIN; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TRAPEZIUS MUSCLE; TRIGGER POINT; ULTRASOUND THERAPY; VISUAL ANALOG SCALE;

EID: 34249864418     PISSN: 10538127     EISSN: None     Source Type: Journal    
DOI: 10.3233/BMR-2007-20107     Document Type: Article

References (25)

1. J.R. Basford, The physical agents, in: Physical Medicine and Rehabilitation: The Complete Approach, M. Grabois, S.J. Garrison, K.A. Hart and D. Lehmkuhl, eds, Blackwell Science, Cambridge, 2000, p. 429.
2. J.R. Basford, The physical agents, in: Physical Medicine and Rehabilitation: The Complete Approach, M. Grabois, S.J. Garrison, K.A. Hart and D. Lehmkuhl, eds, Blackwell Science, Cambridge 429, 2000.
3. W.P. Cheshire, S.W. Abashian and J.D. Mann, Botulinum toxin in the treatment of myofascial pain syndrome, Pain 59 (1994), 65-69.
4. T.M. Cummings and A.R. White, Needling therapies in the management of myofascial trigger point pain: A systematic review, Arch Phys Med Rehabil 82 (2001), 986-992.
5. M. Esenyel, N. Caglar and T. Aldemir, Treatment of myofascial pain, Am J Phys Med Rehabil 79 (2000), 48-52.
6. P. Greene, U. Kang, S. Fahn, M. Brin, C. Moskowitz and E. Flaster, Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis, Neurology 40 (1990), 1213-1218.
7. S.R. Hameroff, B.R. Crago, C.D. Blitt, J. Womble and J. Kanel, Comparison of bupivacaine, etidocaine, and saline for trigger-point therapy, Anesth Analg 60 (1981), 752-755.
8. W.P. Hanten, S.L. Olson, N.L. Butts and A.L. Nowicki, Effectiveness of a home program of ischemic pressure followed by sustained stretching for treatment of myofascial trigger points, Phys Ther 80 (2000), 997-1003.
9. C.Z. Hong, Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response, Am J Phys Med Rehabil 73 (1994), 256-263.
10. C.Z. Hong, Lidocaine injection versus dry needling to myofascial trigger point, Am J Phys Med Rehabil 73 (1994), 256-263.
11. T.C. Hsueh, P.T. Cheng, T.S. Kuan and C.Z. Hong, The immediate effectiveness of electrical nerve stimulation and electrical muscle stimulation on myofascial trigger points, Am J Phys Med Rehabil 76 (1997), 471-476.
12. H. Ishikawa, Y. Mitsui, T. Yoshitomi et al., Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles, Jpn J Ophthalmol 44 (2000), 106-109.
13. A. Kamanli, A. Kaya, O. Ardicoglu, S. Ozgocmen, F. Ozkurt Zengin and Y. Bay, Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome, Rheumatol Int 25(8) (2005), 604-611.
14. A.M. Lang, Botulinum toxin type A therapy in chronic pain disorders, Arch Phys Med Rehabil 84(Suppl 1) (2003), S69-S73.
15. S.P. Long and W. Kephart, Myofascial pain syndrome, in: The Management of Pain, M.A. Ashburn and L.J. Rice, eds, Churchill Livingstone, Philadelphia, 1998, pp. 299-321.
16. J. Majlesi and H. Ünalan, High-power pain threshold ultrasound technique in the treatment of active myofascial trigger points: A randomized, double-blind, case-control study, Arch Phys Med Rehabil 85 (2004), 833-836.
17. M. Naumann, A. Yakovleff and F. Durif, A randomized, double-masked, crossover comparison of the efficacy and safety of botulism toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia, J Neurol 249 (2002), 57-63.
18. N.B. Rosen, Physical medicine and rehabilitation approaches to the management of myofascial pain and fibromyalgia syndromes, Baillieres Clin Rheumatol 8 (1994), 881-916.
19. D.G. Simons, J.G. Travell and L.S. Simons, Myofascial Pain and Dysfunction: The Trigger Point Manual, (Vol. 1), Upper Half of Body, Baltimore: Williams & Wilkins, 1983.
20. A.E. Sola and J.J. Bonica, Myofascial pain syndromes, in: The Management of Pain, J.J. Bonica, ed., Lea and Febiger, Philadelphia, 1990, pp. 352-367.
21. K.P. Tschopp and C. Gysin, Local injection therapy in 107 patients with myofascial pain syndrome of the head and neck, ORL J Otorhinolaryngol Relat Spec 58 (1996), 306-310.
22. D.C. Weber and A.W. Brown, Physical agent modalities, in: Physical Medicine and Rehabilitation, R.L. Braddom, ed., WB Saunders, Philadelphia, 2000, pp. 446-447.
23. D.C. Weber and A.W. Brown, Physical agent modalities, in: Physical Medicine and Rehabilitation, R.L. Braddom, ed., WB Saunders, Philadelphia, 2000, pp. 446-447.
24. M.J. Welch, J.R. Purkiss and K.A. Foster, Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins, Toxicon 38 (2000), 245-258.
25. A.H. Wheeler, P. Goolkasian and S.S. Gretz, A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome, Spine 23 (1998), 1662-1666.